NIH RAC should encourage serious disease studies over genetic enhancement protocols -- NORD's Langan.
Executive Summary
NIH RAC SHOULD PROMOTE SERIOUS GENETIC DISEASE PROTOCOLS OVER ENHANCEMENT studies, National Organization for Rare Disorders VP-Public Policy Michael Langan, urged at the first NIH gene therapy policy conference on genetic enhancement. The National Institutes of Health Recombinant DNA Advisory Committee should consider "a way to encourage more scientists to research these truly serious and life-threatening diseases, and to discourage enhancement," Langan said at the Sept. 11 meeting in Bethesda, Md.